
Over the last decade, the advent of molecular targeted therapy radically changed the treatment of several forms of zzso However, these innovative zzso drugs, namely zzso zzso and small zzso zzso zzso zzso were found to adversely affect cardiovascular zzso These zzso and zzso drug side effects zzso a wide range of zzso zzso including left zzso dysfunction leading to heart failure, zzso abnormalities with zzso hypertension, zzso zzso and zzso zzso The unclear zzso of drug-induced cardiovascular events together with uncertainty on their zzso and long-term safety call for a multidisciplinary effort embracing zzso expertise supported by primary care physicians, zzso and zzso Here we address emerging cardiovascular events associated with targeted zzso drugs by offering a concise review on: zzso zzso basis zzso zzso and zzso clinical advice for effective patient management zzso zzso treatment, monitoring and reporting of cardiovascular side zzso In this scenario, zzso zzso zzso oriented to zzso zzso is emerging as a key to support zzso in appropriateness zzso 

